全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Exman Pedro , Barroso-Sousa Romualdo , Tolaney Sara M
来源:[J].OncoTargets and therapy(IF 2.073), 2019, Vol.12, pp.5177-5187PubMed
摘要:Approximately 5-10% of all patients diagnosed with breast cancer have germline BRCA1/2 mutations, which make their disease more susceptible to DNA-damaging agents and a new class of drugs known as poly(ADP-ribose) polymerase (PARP) inhibitors. Talazoparib is a new PARP inhibitor ...
作者:Exman Pedro , Testa Laura ...
来源:[J].World journal of oncology, 2019, Vol.10 (1), pp.28-34PubMed
摘要:Although a rare and challenging condition, cancer during pregnancy should promptly be identified and treated. Not only standards of care guidelines for the underlying disease are taken into account, but also fetal safety might be weighted for clinical decisions. Frequent lack of ...
作者:Exman Pedro , Takahashi Tiago Kenji ...
来源:[J].Rare tumors, 2013, Vol.5 (2), pp.89-92PubMed
摘要:Primary choriocarcinoma of the ovary is rare. Furthermore, this tumor can arise from gestational tissue or pure germ cells of the ovary, with the latter resulting in non-gestational choriocarcinoma. While the clinical characteristics and histology of both tumor types are identica...
作者:... Lii Joyce , Exman Pedro , Barry William T
来源:[J].Cancer, 2018PubMed
摘要:Although breast cancer often is perceived to be indolent in older women, breast cancer outcomes in the oldest patients are variable. In the current study, the authors examined breast cancer-specific death by age, stage, and disease subtype in a large, population-based cohort...
作者:... Lii Joyce , Exman Pedro , Barry William T
来源:[J].Cancer, 2018, Vol.124 (10), pp.2184-2191PubMed
摘要:BACKGROUND(#br)Although breast cancer often is perceived to be indolent in older women, breast cancer outcomes in the oldest patients are variable. In the current study, the authors examined breast cancer-specific death by age, stage, and disease subtype in a large, populati...
作者:Barroso-Sousa Romualdo , Exman Pedro , Tolaney Sara M
来源:[J].Future oncology (London, England), 2018PubMed
摘要:The decision to offer adjuvant therapy to patients with early-stage cancer relies on factors related to the risk of disease recurrence, degree of benefit with the proposed therapy and the associated risk of toxicities. For patients with stages II and III HER2-positive breast canc...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×